CMS Advisory Committee Supports Humanitarian-Device Trial Coverage
This article was originally published in The Gray Sheet
Executive Summary
A Medicare advisory panel voted overwhelmingly Dec. 13 to allow coverage of all humanitarian-use devices in studies that fall under the agency's revised clinical research policy